May 20, 2026 · Integration · 9 min read

Antibiotics the way Step asks them

Antibiotics on Step 2 and Step 3 are not a pharmacology topic. They are an integration topic. Nobody is asking you to recite the mechanism of vancomycin. They are asking what you start in a hypotensive cirrhotic with ascites, why the resident’s pick is wrong, and what the side effect is going to be three days from now. Four linked questions, every time. If you study antibiotics as a drug list, you will miss them as questions.

The four-question chain

Every antibiotic stem on Step is the same chain. The test asks one link explicitly and hides the rest in the distractors.

1. The bug. What organism is the stem pointing at? Almost never named — it is encoded in age, exposure, immune status, and source.
2. The drug. What is the empiric regimen that covers the bug and the realistic differential at that source?
3. The gap. What does the wrong answer fail to cover? Every distractor is a coverage gap, and the gap is almost always the entire reason it is wrong.
4. The trap. What side effect, interaction, or modifier is the next question going to ask about? Pregnancy, renal function, QT, warfarin, statin, SSRI, G6PD, sulfa allergy — the trap layer is where Step 3 in particular lives.

Two creators teach this chain better than anyone outside a tutoring room. The Match Guy drills links one and two — scenario, bug, empiric drug, what each drug actually covers. Divine Intervention drills links three and four — the coverage gaps that explain the distractors and the side-effect web that powers the “three days later” follow-up question. If you have not listened to both, do that before your dedicated. This post is the chain itself, with the highest-yield content under each link.

Link 1 — the bug, encoded

The stem will not say Listeria. It will say a 72-year-old with confusion and a stiff neck. It will not say Pseudomonas. It will say a ventilated ICU patient on day eight, or a diabetic with a foot ulcer that smells, or a neutropenic patient spiking through cefepime. The bug is encoded; your job is to decode before you read the answer choices.

The encodings worth knowing cold:

• Meningitis. Neonate → GBS, E. coli, Listeria. Child/adult → pneumococcus, meningococcus. >50, alcoholic, immunocompromised, pregnant → add Listeria back in. Post-neurosurgical or VP shunt → staph (including MRSA) and gram negatives including Pseudomonas.
• Pneumonia. Outpatient CAP → pneumococcus, atypicals. Inpatient CAP → same plus Legionella. HAP/VAP → MRSA + Pseudomonas. Aspiration → oral anaerobes + gram negatives. Post-influenza → S. aureus. Cystic fibrosis → Pseudomonas, Burkholderia. Alcoholic → Klebsiella (currant jelly).
• UTI / pyelo. E. coli by default. Young woman, honeymoon → consider Staph saprophyticus. Catheter, recent hospitalization, recent antibiotics → resistant gram negatives, Pseudomonas, Enterococcus.
• Endocarditis. Native valve → Strep viridans (after dental work), S. aureus. IVDU → S. aureus, right-sided. Prosthetic valve, early → coag-negative staph. Colon cancer in the stem → Strep gallolyticus (bovis). HACEK with culture-negative.
• Skin and soft tissue. Non-purulent cellulitis → strep. Purulent / abscess → S. aureus, assume MRSA possible. Diabetic foot → polymicrobial including anaerobes and Pseudomonas. Hot tub / puncture through a sneaker → Pseudomonas. Cat bite → Pasteurella. Human bite → Eikenella.
• Intra-abdominal. Gut flora → gram negatives + anaerobes + enterococci. SBP in a cirrhotic → E. coli, Klebsiella, pneumococcus (monomicrobial — if it’s polymicrobial think secondary peritonitis from perforation).
• Neutropenic fever. Anything, but cover Pseudomonas. Add vanc if line infection, mucositis, hemodynamic instability, or skin source. Add antifungal if persistent fevers past four to seven days.
• Sepsis without a source. Broad gram positive + gram negative + Pseudomonas. The question is asking you to not wait.

Decode first, choose second. If you go to the answer choices without the bug already named in your head, you are picking based on what the choices look like — which is exactly what the distractors are designed to exploit.

Link 2 — the drug, by source

The empiric pairs that come up over and over. Memorize the regimen and the bug it is built to cover, because the distractors are usually a drug that hits two of three and misses one.

• Bacterial meningitis, adult. Ceftriaxone + vancomycin. Add ampicillin if >50, alcoholic, immunocompromised, pregnant — that is the Listeria add-back. Dexamethasone before or with the first dose if pneumococcal suspected.
• CAP, outpatient, healthy. Amoxicillin or doxycycline or a macrolide. Comorbid or recent antibiotics → amox/clav + macrolide or doxycycline, or respiratory fluoroquinolone.
• CAP, inpatient. Ceftriaxone + azithromycin, or a respiratory fluoroquinolone alone.
• HAP / VAP. Antipseudomonal beta-lactam (pip-tazo, cefepime, or meropenem) + MRSA coverage (vanc or linezolid). Add a second antipseudomonal (FQ or aminoglycoside) if risk factors for resistance.
• Aspiration pneumonia. Amp-sulbactam or pip-tazo. Add coverage for resistant organisms if hospital-acquired.
• Uncomplicated cystitis. Nitrofurantoin, TMP-SMX, or fosfomycin. FQs are not first line anymore for uncomplicated UTI — that is a Step 3 trap.
• Pyelonephritis, outpatient. Fluoroquinolone. Inpatient → ceftriaxone or pip-tazo.
• Cellulitis, non-purulent. Cephalexin or dicloxacillin. Add MRSA coverage (doxy, TMP-SMX, clinda) if purulent or risk factors.
• Diabetic foot, severe. Pip-tazo or carbapenem. Add vanc if MRSA risk.
• SBP. Ceftriaxone. Plus albumin if Cr >1, BUN >30, or bilirubin >4.
• Endocarditis, native valve, empiric. Vanc + ceftriaxone while cultures cook.
• Neutropenic fever. Cefepime, pip-tazo, or meropenem monotherapy. Add vanc for the specific triggers above.
• Septic arthritis. Vanc + ceftriaxone. Sexually active young adult → ceftriaxone alone covers gonococcal.

Link 3 — the gap (why the distractor fails)

This is the link most students skip, and it is where the points are. Every wrong drug on the answer list is wrong for one reason: it leaves a hole. Learn the holes by drug, and the distractors stop looking plausible.

• Ceftriaxone does not cover Listeria, Pseudomonas, MRSA, Enterococcus, or atypicals. So a meningitis stem in a 75-year-old where the choice is ceftriaxone + vanc — that misses Listeria. Add ampicillin.
• Vancomycin does not cover any gram negatives. So “vanc and gent” is not a meningitis regimen. It is what you use post-neurosurgery plus something with CNS-penetrant gram-negative and Pseudomonas coverage like cefepime or meropenem.
• Pip-tazo covers Pseudomonas, anaerobes, most gram negatives, MSSA, enterococci. It does not reliably cover MRSA or atypicals. So pip-tazo alone is not HAP coverage if MRSA is on the table.
• Carbapenems do not cover MRSA or atypicals, and ertapenem does not cover Pseudomonas. The last point is the trap — students assume all carbapenems are equivalent.
• Daptomycin is inactivated by surfactant. It does not work in the lung. Pneumonia + daptomycin in the answer choices is always wrong.
• Aminoglycosides do not penetrate the CNS well and do not work in anaerobic, abscess, or low-pH environments. So gentamicin for meningitis or a closed-space abscess is wrong even when the bug would otherwise be sensitive.
• Nitrofurantoin and fosfomycin do not achieve tissue levels — cystitis only. They are wrong answers for pyelonephritis even when the organism is sensitive.
• Clindamycin covers gram positives including MRSA and anaerobes above the diaphragm. It is not your below-the-diaphragm anaerobe drug — that is metronidazole.
• Macrolides and doxycycline cover atypicals but miss serious gram negatives. They are outpatient drugs.

Link 4 — the trap (what gets asked three days later)

This is where Step 3 lives, and where Step 2 has been migrating. The stem starts the antibiotic. The question is about the consequence. Learn the side-effect and interaction map by drug, because the second-order question is where the easy points sit if you have it loaded.

Side effects with stem-level fingerprints

• Fluoroquinolones. Tendon rupture (especially Achilles, especially on steroids, especially elderly). QT prolongation. Aortic aneurysm and dissection risk — avoid in patients with known aneurysm. Hypoglycemia, especially with sulfonylureas. CNS effects in elderly. Avoid in pregnancy and children for cartilage.
• Aminoglycosides. Nephrotoxicity and ototoxicity. The ototoxicity is often permanent. Neuromuscular blockade — dangerous in myasthenia gravis.
• Vancomycin. Red man syndrome (rate-related, not allergy — slow the infusion, do not switch the drug). Nephrotoxicity especially with concurrent pip-tazo or aminoglycosides. Trough monitoring on Step 3.
• Linezolid. Thrombocytopenia. Lactic acidosis. Serotonin syndrome when combined with SSRIs, SNRIs, MAOIs, tramadol. Peripheral and optic neuropathy with prolonged use.
• Daptomycin. CK elevation and myopathy — hold statins while on it.
• Clindamycin. C. difficile. The classic association, still tested.
• TMP-SMX. Hyperkalemia (blocks ENaC). Acute kidney injury (trimethoprim raises creatinine without changing GFR — know both versions). Stevens-Johnson. Sulfa allergy. Kernicterus in late pregnancy. Hemolysis in G6PD.
• Tetracyclines. Teeth and bone in kids and pregnancy. Photosensitivity. Esophagitis if taken lying down.
• Macrolides. QT prolongation. CYP3A4 inhibition (interactions below).
• Metronidazole. Disulfiram reaction with alcohol. Metallic taste. Peripheral neuropathy on prolonged use.
• Rifampin. Orange tears, urine, sweat. Hepatotoxicity. Potent CYP inducer — the inducer everyone forgets.
• Isoniazid. Hepatotoxicity. B6 deficiency neuropathy — co-administer pyridoxine. SLE-like syndrome in slow acetylators.

The interactions that show up as “three days later”

• Warfarin INR jumps. Metronidazole, TMP-SMX, macrolides, fluoroquinolones. If the stem starts any of these and the next visit is bleeding or supratherapeutic INR, the antibiotic is the answer.
• Statin + macrolide or azole = rhabdo. Clarithromycin and erythromycin are CYP3A4 inhibitors. Azithromycin is the safer one in this specific interaction.
• OCP failure with rifampin. The induction is real and tested. Counsel backup contraception.
• SSRI + linezolid = serotonin syndrome. Wash out or pick a different antibiotic.
• Sulfonylurea + fluoroquinolone = hypoglycemia. Especially in the elderly diabetic.
• ACEi or ARB or spironolactone + TMP-SMX = hyperkalemia. Check a potassium.

Modifiers Step loves

• Pregnancy. Safe: penicillins, cephalosporins, azithromycin, clindamycin. Cystitis in pregnancy: nitrofurantoin (avoid at term), cephalexin, fosfomycin — treat asymptomatic bacteriuria, which you do not treat outside pregnancy. Avoid: fluoroquinolones, tetracyclines, aminoglycosides, TMP-SMX in T1 (folate antagonist) and T3 (kernicterus).
• Penicillin allergy. True anaphylaxis → avoid all beta-lactams in the highest-risk stems, though cephalosporin cross-reactivity is lower than older teaching suggested. Rash only → cephalosporins are generally safe. Aztreonam is the safe gram-negative drug across the board.
• Renal dose adjustment. Vanc, aminoglycosides, beta-lactams (most), fluoroquinolones, TMP-SMX. Not adjusted: ceftriaxone, azithromycin, doxycycline, metronidazole, linezolid, clindamycin — the “safe in renal failure” list.

The drug is link two. The points are in links three and four.

Step 3 specifically

Step 3 adds three layers on top of the Step 2 framework, and antibiotics show up in all three.

• CCS cases. Order cultures before the antibiotic, then start the antibiotic without waiting for results. The order matters and the timer is real. Narrow when sensitivities return. Stop when the indication ends.
• IV to PO transition. Patient afebrile 24–48 hours, hemodynamically stable, tolerating PO, gut working, source controlled. Then switch — usually to the same class or to the highest-bioavailability oral option (fluoroquinolones, linezolid, doxycycline, metronidazole, TMP-SMX all have excellent oral bioavailability).
• Outpatient management with comorbidities. The elderly diabetic on warfarin and a sulfonylurea who needs an antibiotic for cellulitis — the question is about which antibiotic avoids the three interactions you just learned. That is a Step 3 question almost verbatim.

How to drill this

Three passes. First pass: take a blank page and rebuild the bug encodings by source from memory. If you cannot generate the list for meningitis-by-age or pneumonia-by-setting without looking, you are not at link one yet. Second pass: for every empiric regimen in this post, write the coverage gap of each component — what does it miss? That is link three loaded into long-term memory. Third pass: shuffle. Pick a random antibiotic and force yourself to recite the side-effect fingerprint, the interactions, and the pregnancy and renal modifiers. When all three passes feel boring, you are at the level the test is asking for.

This is the same logic we use for any high-volume topic — collapse the list into a small number of organizing buckets, then load the stem-to-answer equations until they fire automatically. Antibiotics just have four buckets stacked on top of each other instead of one.

Want this kind of integration map built for the topics that are still costing you points? The free 15-minute intro call is a quick read on which topics need a framework rebuild and which just need more reps. Book the call →